Evaluating the Impact of Test-and-Treat on the HIV Epidemic among MSM in China Using a Mathematical Model.

Early HAART Initiation May Not Reduce Actual Reproduction Number and Prevalence of MSM Infection: Perspectives from Coupled within- and between-Host Modelling Studies of Chinese MSM Populations. PLoS One (2016) 0.76

Expanded antiretroviral treatment, sexual networks, and condom use: Treatment as prevention unlikely to succeed without partner reduction among men who have sex with men in China. PLoS One (2017) 0.75

Predicting and Evaluating the Epidemic Trend of Ebola Virus Disease in the 2014-2015 Outbreak and the Effects of Intervention Measures. PLoS One (2016) 0.75

Enhancing HIV Testing and Treatment among Men Who Have Sex with Men in China: A Pilot Model with Two-Rapid Tests, Single Blood Draw Session, and Intensified Case Management in Six Cities in 2013. PLoS One (2016) 0.75

Barriers and facilitators of linkage to HIV care among HIV-infected young Chinese men who have sex with men: a qualitative study. BMC Health Serv Res (2017) 0.75

Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med (2011) 69.36

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01

Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis (2005) 21.08

Brief but efficient: acute HIV infection and the sexual transmission of HIV. J Infect Dis (2004) 8.30

Universal voluntary testing and treatment for prevention of HIV transmission. JAMA (2009) 7.20

A tale of two futures: HIV and antiretroviral therapy in San Francisco. Science (2000) 5.52

HIV viral load markers in clinical practice. Nat Med (1996) 4.78

CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression. Clin Infect Dis (2006) 4.67

Rethinking prevention of HIV type 1 infection. Clin Infect Dis (2010) 4.19

Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS (2010) 4.05

HIV-1 treatment as prevention: the good, the bad, and the challenges. Curr Opin HIV AIDS (2011) 3.39

Expanded access to highly active antiretroviral therapy: a potentially powerful strategy to curb the growth of the HIV epidemic. J Infect Dis (2008) 3.38

HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr (2007) 3.38

Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals. AIDS (2010) 2.98

Immunopathogenic mechanisms of HIV infection. Ann Intern Med (1996) 2.61

Universal testing and treatment as an HIV prevention strategy: research questions and methods. Curr HIV Res (2011) 2.60

Test and treat DC: forecasting the impact of a comprehensive HIV strategy in Washington DC. Clin Infect Dis (2010) 2.28

The effect of expanded antiretroviral treatment strategies on the HIV epidemic among men who have sex with men in San Francisco. Clin Infect Dis (2011) 2.20

Treating our way out of the HIV pandemic: could we, would we, should we? Lancet (2008) 1.78

Should we try to eliminate HIV epidemics by using a 'Test and Treat' strategy? AIDS (2010) 1.57

A mathematical model of comprehensive test-and-treat services and HIV incidence among men who have sex with men in the United States. PLoS One (2012) 1.50

Rate of CD4 decline and HIV-RNA change following HIV seroconversion in men who have sex with men: a comparison between the Beijing PRIMO and CASCADE cohorts. J Acquir Immune Defic Syndr (2013) 1.10

Costs of eliminating HIV in South Africa have been underestimated. Lancet (2010) 1.03

Test and treat may not be best approach in South Africa, according to new study. IAVI Rep (2012) 0.78